Canada - engelsk - Health Canada

genmed a division of pfizer canada ulc - quinapril (quinapril hydrochloride) - tablet - 10mg - quinapril (quinapril hydrochloride) 10mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

genmed a division of pfizer canada ulc - quinapril (quinapril hydrochloride) - tablet - 20mg - quinapril (quinapril hydrochloride) 20mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

genmed a division of pfizer canada ulc - quinapril (quinapril hydrochloride) - tablet - 40mg - quinapril (quinapril hydrochloride) 40mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

sun pharma canada inc - quinapril (quinapril hydrochloride) - tablet - 10mg - quinapril (quinapril hydrochloride) 10mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

apotex inc - quinapril (quinapril hydrochloride) - tablet - 5mg - quinapril (quinapril hydrochloride) 5mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

apotex inc - quinapril (quinapril hydrochloride) - tablet - 10mg - quinapril (quinapril hydrochloride) 10mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

apotex inc - quinapril (quinapril hydrochloride) - tablet - 20mg - quinapril (quinapril hydrochloride) 20mg - angiotensin-converting enzyme inhibitors

Canada - engelsk - Health Canada

apotex inc - quinapril (quinapril hydrochloride) - tablet - 40mg - quinapril (quinapril hydrochloride) 40mg - angiotensin-converting enzyme inhibitors

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - quinapril hydrochloride -

USA - engelsk - NLM (National Library of Medicine)

cipla usa inc. - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 5 mg - hypertension quinapril is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with quinapril. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of